Sword Health
Sword Health delivers AI-powered virtual physical therapy via its FDA-listed Digital Therapist, significantly reducing pain and surgery intent.
Secondary Market Price
Secondary Market Price
Secondary Market Price Chart
Secondary market prices shown here are a limited preview. Create a free account to access real-time secondary market prices.
Sign up to Unlock the Latest DataProspect Projected Future Sword Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Sword Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Sword Health is a virtual musculoskeletal (MSK) care provider that delivers personalized physical therapy to patients at home. The company’s platform uses an FDA-listed device called the Digital Therapist, which combines motion sensors and artificial intelligence to guide users through evidence-based exercise programs. Licensed physical therapists remotely supervise patient progress, providing treatment for acute, chronic, and post-surgical pain. Founded in 2015 by Virgílio Bento and Márcio Colunas, Sword Health was established with the goal of making high-quality MSK care more accessible and affordable for a global market.
Looking forward, Sword Health is focused on expansion and has announced plans to move into new treatment areas, including women's health, while also pursuing strategic acquisitions. A recent example of this strategy is its acquisition of Surgery Hero in January 2025. The company's growth is backed by significant investor confidence, with a funding round in June 2024 bringing its valuation to $3 billion. Beyond its own platform, Sword Health is also working to influence the broader healthcare landscape, actively supporting legislation like Illinois SB 2153 to expand patient access to virtual physical therapy.
- General Catalyst
- Khosla
- Founders Fund
- Sapphire Ventures
- BOND
- Lachy Groom
- Transformation Capital
- LocalGlobe
- Sozo Ventures
- Willoughby Capital
- Co-Founder, CEO Virgílio Bento
- Co-Founder, CSO Márcio Colunas
Peer Group Comparison
Vs Peer Group of >$4B Startups
How Sword Health Measures Up
To help you manage your Sword Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
2x
Based on our analysis, we project Sword Health will be worth at least 2x its current valuation in four years. For prospective employees, this rating suggests a moderate potential for equity growth combined with a lower risk of company failure.
Exit Risk
Low Risk
Our “Low Risk” rating for Sword Health reflects a lower likelihood of the company failing to reach a liquidity event compared to other startups, primarily because it is backed by top investors.
Funding Stage
Funding
For a potential employee, Sword Health's strong financial backing suggests a stable environment with a lower risk of downsizing. This also means the company has the resources to invest in its own expansion and the professional growth of its team.
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Sword Health worth joining?
Sword Health is a fast-growing company in the large musculoskeletal care market, backed by top-tier investors like General Catalyst and Khosla Ventures. You can use platforms like Prospect to independently evaluate its growth potential and compare it to other high-potential startups.
What should I do with my Sword Health stock?
Managing equity in a private company like Sword Health requires understanding its potential value, tax implications, and liquidity options. An equity management platform can help you model different financial scenarios and create a tax-optimized strategy for your shares.
Can you sell Sword Health stock?
As Sword Health is a private company, its stock is not traded on public exchanges, which makes selling shares more complicated than for a public company. Employees and investors may have opportunities to sell shares through secondary markets, and platforms like Prospect can provide data on market prices and tax-efficient selling strategies.
How can I find the value of my Sword Health stock?
The value of private stock is typically based on the company's most recent 409A valuation or the price set during its latest funding round. You can use the company's $3 billion valuation as a starting point and leverage an equity calculator to estimate the potential net value of your specific holdings.
What is Sword Health's equity worth?
Based on its most recent Series D funding round in June 2024, Sword Health has a total equity valuation of $3 billion. This figure represents the company's total estimated worth, which is used to determine the price per share for investors and employees.
What is Sword Health's stock ticker symbol?
Sword Health is a private company and has not conducted an Initial Public Offering (IPO), so it does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they begin trading on a public stock exchange.
Can I buy or sell Sword Health stock?
Since Sword Health is private, its stock is not available for purchase by the general public on exchanges like the NYSE or NASDAQ. Selling is sometimes possible for employees and early investors through secondary market transactions, but these are not guaranteed and are subject to company policies.
What is the criteria to buy or invest in Sword Health stock?
Investing in a private, late-stage startup like Sword Health is generally restricted to accredited investors and institutional funds that participate in organized funding rounds. The company does not offer a direct stock purchase plan for the general public at this time.
